Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MeTEPsA Trial
NCT07486843Phase 4Recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in psoriatic arthritis (PsA), sponsored by The Chinese University of Hong Kong. Started Mar 2026; status: recruiting.
02
Drugs
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT07486843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486843.